AIM IHT
Market delights | Margin concerns | Stonking Small Cap update
Results and updates covered here include positive news (at long last) from a developer of sustainable energy projects. Elsewhere, we are less impressed with results from a distributor of building materials, whose margins and strange mix of activities leave us scratching our heads. One of our Stonking Small Cap opportunities also continues to impress.
Advanced Medical: US regulatory approval
Advanced Medical Solutions (AIM: AMS), the world-leading specialist in tissue-healing technologies, has received US FDA approval for LiquiBand® XL, a new device that can close longer wounds than existing LiquiBand® products. The product launch into the US is expected in the third quarter of 2022 with strong demand for the new product from hospitals and the Group’s distribution partners.
Previous article Next article
